← All companies

LEGN

Legend Biotech Corporation

LEGN Nasdaq Pharmaceutical Preparations EDGAR ↗

$19.01

+0.46 +2.48%

Key statistics

from XBRL data in SEC filings

Market cap

$7.03B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$16.24 – $39.16

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 27, 2026 6-K FORM 6-K Jul 15, 2026 6-K Jun 22, 2026 6-K FORM 6-K Jun 15, 2026 6-K FORM 6-K Jun 2, 2026 6-K FORM 6-K Jun 1, 2026 6-K FORM 6-K May 21, 2026 6-K May 12, 2026 6-K FORM 6-K Apr 14, 2026 20-F Mar 10, 2026 6-K FORM 6-K Mar 10, 2026 6-K FORM 6-K Feb 6, 2026 6-K FORM 6-K Jan 23, 2026 6-K FORM 6-K Jan 21, 2026 6-K FORM 6-K Jan 14, 2026 6-K FORM 6-K Jan 12, 2026 6-K FORM 6-K Dec 8, 2025 6-K Nov 12, 2025 6-K FORM 6-K Nov 3, 2025 6-K FORM 6-K Oct 14, 2025 6-K FORM 6-K Oct 14, 2025 6-K FORM 6-K Oct 7, 2025 6-K FORM 6-K Aug 18, 2025 6-K Aug 11, 2025 6-K FORM 6-K Jul 16, 2025 6-K FORM 6-K Jun 30, 2025 6-K FORM 6-K Jun 12, 2025 6-K FORM 6-K Jun 6, 2025 6-K FORM 6-K Jun 5, 2025 6-K FORM 6-K Jun 3, 2025 6-K FORM 6-K May 23, 2025 6-K FORM 6-K May 14, 2025 6-K May 13, 2025 6-K May 12, 2025 6-K FORM 6-K Apr 15, 2025 20-F Mar 11, 2025 6-K FORM 6-K Mar 11, 2025 6-K FORM 6-K Jan 22, 2025 6-K FORM 6-K Jan 14, 2025 6-K FORM 6-K Dec 23, 2024